Eyewear maker Inspecs H1 revenue rises on manufacturing growth
Eyewear maker Inspecs H1 revenue rises on manufacturing growth
Overview
UK eyewear maker's H1 revenue rose 1.6% year-over-year
Underlying EBITDA for H1 climbed 13.1% as cost controls improved margins
Company completed £7.4 mln strategic investment from Qualcomm, reducing net debt
Outlook
Company says market conditions remain challenging, especially in US and German markets
Inspecs remains focused on operational efficiencies, cost control and developing new business opportunities
Company reiterates medium-term target of organic revenue growth 40% above market rate
Result Drivers
OPERATIONAL EFFICIENCIES - Co said improved profitability reflected operational efficiencies and cost-reduction initiatives across the group
MANUFACTURING GROWTH - Manufacturing revenue rose 33% due in part to delayed orders from 2025 being shipped in early 2026 and improved factory performance
CHALLENGING MARKETS - Co said subdued demand in US optical frames and German low vision markets weighed on overall growth, partly offset by growth in Eschenbach eyewear
Company press release: ID:nRSJ0926Ua
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| GBP 99.10 mln |
|
H1 Adjusted EBITDA |
| GBP 10.20 mln |
|
H1 Gross Margin |
| 52.70% |
|
Reuters Recommended Reads
Sept 7 - Son of EssilorLuxottica founder calls for new strategy for eyewear group
Sept 9 - Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)